These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 5527023

  • 1. Implications of biochemical, cytokinetic, pharmacologic, and toxicologic relationships in the design of optimal therapeutic schedules.
    Skipper HE, Schabel FM, Mellett LB, Montgomery JA, Wilkoff LJ, Lloyd HH, Brockman RW.
    Cancer Chemother Rep; 1970 Dec; 54(6):431-50. PubMed ID: 5527023
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The effect of dose interval on the survival of L1210 leukemic mice treated with DNA synthesis inhibitors.
    Neil GL, Homan ER.
    Cancer Res; 1973 Apr; 33(4):895-901. PubMed ID: 4696483
    [No Abstract] [Full Text] [Related]

  • 4. [L 1210 leukemia, an experimental model for the potentiation of drugs used for acute leukemias].
    Pouillart P, Huong TH, Lhéritier J.
    Bull Cancer; 1974 Apr; 61(4):509-26. PubMed ID: 4458834
    [No Abstract] [Full Text] [Related]

  • 5. Intravaginal and intrarectal screening of antimitotic drugs for topical effectiveness.
    Van Scott EJ, Bonder RH.
    J Invest Dermatol; 1971 Feb; 56(2):132-9. PubMed ID: 5556503
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Effects of combination chemotherapy of MCNU with various anti-cancer agents].
    Machida S, Ito Y, Hoshino A.
    Gan To Kagaku Ryoho; 1985 Feb; 12(2):298-302. PubMed ID: 3918506
    [Abstract] [Full Text] [Related]

  • 8. [Chemotherapy of L1210 leukemia: comparison of 7 drugs given either continuously for 20 days, or in a single massive dose, early or late].
    Mathé G, Schwarzenberg L, Hayat M, Schneider M.
    Rev Fr Etud Clin Biol; 1968 Dec; 13(10):951-60. PubMed ID: 5306738
    [No Abstract] [Full Text] [Related]

  • 9. Rationale of chemotherapeutic adjuvant treatment.
    Goldin A.
    Arch Geschwulstforsch; 1978 Dec; 48(7):627-35. PubMed ID: 736743
    [No Abstract] [Full Text] [Related]

  • 10. Combined therapy of L1210 leukemia with Damvar and cytostatics.
    Pujman V, Cernochová S.
    Neoplasma; 1979 Dec; 26(5):521-3. PubMed ID: 522924
    [Abstract] [Full Text] [Related]

  • 11. Chemotherapy and the life cycle of leukaemic cells. A comparison between the growth characteristics of human acute leukaemia and the murine leukaemia L 1210.
    Benckhuijsen C.
    Folia Med Neerl; 1969 Dec 02; 12(2):74-84. PubMed ID: 4894168
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Biochemical and pharmacologic studies with 1- -D-arabinofuranosylcytosine 5'-adamantoate (NSC-117614), a depot form of cytarabine.
    Neil GL, Buskirk HH, Moxley TE, Manak RC, Kuentzel SL, Bhuyan BK.
    Biochem Pharmacol; 1971 Dec 02; 20(12):3295-308. PubMed ID: 5002403
    [No Abstract] [Full Text] [Related]

  • 14. Basis of observed resistance of L1210 leukemia in mice: methotrexate, 6-thioguanine, 6-methylmercaptopurine riboside, 6-mercaptopurine, 5-fluorouracil, and 1-beta-D-arabinofuranosylcytosine administered in different combinations.
    Kim K, Blechman WJ, Riddle VG, Pardee AB.
    Cancer Res; 1981 Nov 02; 41(11 Pt 1):4529-34. PubMed ID: 7198006
    [Abstract] [Full Text] [Related]

  • 15. Combination chemotherapy in sequence for the treatment of L1210 leukemia.
    Roberts D, Hilliard SL.
    Cancer Res; 1978 Aug 02; 38(8):2317-20. PubMed ID: 667827
    [No Abstract] [Full Text] [Related]

  • 16. [Induction and interval treatment of leukemias in children and juveniles].
    Oehme J, Meyer-Beeck D.
    Dtsch Med Wochenschr; 1969 Sep 26; 94(39):1993-6. PubMed ID: 5352272
    [No Abstract] [Full Text] [Related]

  • 17. [Effect of combination chemotherapy of nitrosourea MCNU with various anti-tumor agents].
    Ninomiya K, Sekido S, Araki T.
    Gan To Kagaku Ryoho; 1984 Jun 26; 11(6):1315-23. PubMed ID: 6428326
    [Abstract] [Full Text] [Related]

  • 18. [Results of complex treatment of adults with myeloblastic leukemia].
    Mazurowa A, Krykowski E, Robak T, Płuzańska A, Polkowska-Kulesza E, Olszańska-Skorek T.
    Pol Tyg Lek; 1980 Aug 04; 35(31):1187-9. PubMed ID: 6933424
    [No Abstract] [Full Text] [Related]

  • 19. Effectiveness of antitumor agents administered subcutaneously to L1210 leukemic mice in silicone rubber devices.
    Neil GL, Scheidt LG, Kuentzel SL, Moxley TE.
    Chemotherapy; 1973 Aug 04; 18(1):27-40. PubMed ID: 4681847
    [No Abstract] [Full Text] [Related]

  • 20. Combination chemotherapy with 4'Demethylepipodophyllotoxin 9-(4,6-0-ethylidene-beta-D-glucopyranoside), VP 16-213 (NSC 141540) in L1210 leukemia.
    Dombernowsky P, Nissen NI.
    Eur J Cancer (1965); 1976 Mar 04; 12(3):181-8. PubMed ID: 939236
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.